Profil
Evy Lundgren-Åkerlund was the founder of Cartela AB, founded in 2000, where the title held was Vice President-Research & Development from 2000 to 2008.
Dr. Lundgren-Åkerlund is the founder of Xintela AB, founded in 2009, holding the title CEO, Head-Business & Administration.
Current jobs include Director at Targinta AB and Associate Professor at the University of Lund.
Former job includes Chief Executive Officer & Head-Operations at Lund Life Science Incubator from 2008 to 2012.
Postes actifs de Evy Lundgren-Åkerlund
| Sociétés | Poste | Début |
|---|---|---|
| XINTELA AB | Fondateur | 01/01/2009 |
Targinta AB
Targinta AB BiotechnologyHealth Technology Develops targeting and toxin-armed antibodies for cancer | Directeur/Membre du Conseil | - |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Evy Lundgren-Åkerlund
| Sociétés | Poste | Fin |
|---|---|---|
Lund Life Science Incubator | Directeur Général | 01/01/2012 |
Cartela AB
Cartela AB Pharmaceuticals: MajorHealth Technology Develops therapies for arthritic diseases | Fondateur | 24/12/2008 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Cartela AB
Cartela AB Pharmaceuticals: MajorHealth Technology Develops therapies for arthritic diseases | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xintela AB
Xintela AB BiotechnologyHealth Technology Provides treatment and medicine for articular cartilage injuries and diseases | Health Technology |
Lund Life Science Incubator | |
Targinta AB
Targinta AB BiotechnologyHealth Technology Develops targeting and toxin-armed antibodies for cancer | Health Technology |
















